SEC Comment Letter for Nuo Therapeutics, Inc. (AURX) (CIK 0001091596) (AURX) — Sep 3, 2009

Nuo Therapeutics, Inc. (AURX) (CIK 0001091596)
Date: Sept. 3, 2009 · CIK: 0001091596 · Accession: 0000000000-09-048913

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 001-32518

Date

September 3, 2009

Author

Not clearly detected

Form

UPLOAD

Company

Nuo Therapeutics, Inc. (AURX) (CIK 0001091596)

Letter

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

DIVISION OF CORPORATION FINANCE

Mail Stop 3030 September 3, 2009

VIA U.S. MAIL

Andrew S. Maslan Chief Financial Officer Cytomedix, Inc. 416 Hungerford Drive, Suite 330 Rockville, Maryland 20850 Re: Cytomedix, Inc. Form 10-K for the year ended December 31, 2008 Filed March 31, 2009 File No. 001-32518 Dear Mr. Maslan: We have completed our review of your Form 10-K and related filings and do not, at this time, have any further comments. S i n c e r e l y , Jeff Jaramillo A c c o u n t i n g B r a n c h C h i e f

Show Raw Text

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

       DIVISION OF
CORPORATION FINANCE

 Mail Stop 3030
September 3, 2009

VIA U.S. MAIL

 Andrew S. Maslan Chief Financial Officer
Cytomedix, Inc.
416 Hungerford Drive, Suite 330 Rockville, Maryland 20850
 Re: Cytomedix, Inc.
  Form 10-K for the year ended December 31, 2008
  Filed March 31, 2009   File No. 001-32518
Dear Mr. Maslan:
  We have completed our review of your Form  10-K and related filings and do not, at this
time, have any further comments.             S i n c e r e l y ,
       Jeff Jaramillo        A c c o u n t i n g  B r a n c h  C h i e f

SecProbe.io